Case Report: Pseudomonas can take a toll on a patient
Related Experiment Video
Updated: Jun 17, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
David K Buchbinder1, Jasjit Singh2, Tuan Dao3
1Department of Hematology, CHOC Chidren's Hospital, Orange, CA, 92868, USA.
Insights
Severe Pseudomonas aeruginosa infections in children may indicate underlying inborn errors of immunity. Early diagnosis through immune function testing and genetic sequencing is crucial for effective treatment and supportive care.
Area of Science:
- Infectious Diseases
- Immunology
- Genetics
Background:
- Pseudomonas aeruginosa (P. aeruginosa) is a Gram-negative bacterium causing severe infections in pediatric patients, including sepsis.
- Host defense against P. aeruginosa involves innate immunity, particularly Toll-like receptors (TLRs) and cytokine production.
- Inborn errors of immunity can predispose individuals to invasive P. aeruginosa infections.
Observation:
- A previously healthy two-year-old female presented with invasive skin, soft tissue, and central nervous system infection due to P. aeruginosa.
- Immune evaluation revealed a decreased cytokine response to TLR agonists.
- Genetic analysis identified a homozygous deletion in IRAK-4, indicating IRAK-4 deficiency.
Findings:
- The patient's severe P. aeruginosa infection was linked to a deficiency in interleukin-1 receptor-associated kinase (IRAK)-4.
- IRAK-4 deficiency impairs the innate immune response, particularly TLR signaling and cytokine generation.
- This case highlights a specific genetic defect predisposing to severe bacterial infections.
Implications:
- Clinicians should consider inborn errors of immunity in all pediatric patients with severe P. aeruginosa infections.
- Functional immune assessments combined with genetic sequencing enable timely diagnosis and management.
- Identifying IRAK-4 deficiency allows for targeted treatment and appropriate supportive care, improving patient outcomes.
Abstract:
Pseudomonas aeruginosa ( P. aeruginosa) is an aerobic Gram-negative bacterium that is implicated in the development of severe systemic infections among pediatric patients. It is identified in hospitalized chronically ill pediatric patients in association with genitourinary, respiratory tract, and skin or soft tissue infections as well as severe and life-threating infection including sepsis. A variety of immunologic mechanisms play a vital role in the host defense mechanisms against invasive infections with P. aeruginosa. Rarely, specific inborn errors of immune function are implicated in deficiencies that predispose to invasive infections with P. aeruginosa. Innate immune function including germ-line encoded pattern recognition receptors such as toll-like receptors (TLRs) and their downstream signaling is vital in the host defense against P. aeruginosa through the generation of antimicrobial peptides, cytokines/chemokines, and shaping of adaptive immune responses. Herein, we describe a previously healthy two-year-old female with an invasive skin, soft tissue, and central nervous system infection secondary to P. aeruginosa. The invasive nature of this infection prompted a careful evaluation for an inborn error of immunity. Decreased cytokine response to agonists of TLRs was documented. Targeted sequencing of interleukin-1 receptor-associated kinase (IRAK)-4 documented a homozygous deletion of exons 8-13 consistent with IRAK-4 deficiency. This report provides a vital educative message in the existing scientific literature by underscoring the importance of considering inborn errors of immunity in all patients with severe P. aeruginosa infections. Functional assessments of immune function often in combination with sequencing can accurately assign a diagnosis in a timely fashion allowing for definitive treatment and the use of necessary supportive care.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia
Pneumonia I: Introduction

